Artiva Biotherapeutics (ARTV) Receivables - Other (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Receivables - Other for 3 consecutive years, with $67000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 54.11% to $67000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67000.0 through Dec 2025, down 54.11% year-over-year, with the annual reading at $67000.0 for FY2025, 54.11% down from the prior year.
- Receivables - Other for Q4 2025 was $67000.0 at Artiva Biotherapeutics, down from $79000.0 in the prior quarter.
- The five-year high for Receivables - Other was $892000.0 in Q2 2024, with the low at $30000.0 in Q2 2025.
- Average Receivables - Other over 3 years is $288000.0, with a median of $139000.0 recorded in 2024.
- Peak annual rise in Receivables - Other hit 40.15% in 2025, while the deepest fall reached 96.64% in 2025.
- Over 3 years, Receivables - Other stood at $724000.0 in 2023, then tumbled by 79.83% to $146000.0 in 2024, then plummeted by 54.11% to $67000.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $67000.0, $79000.0, and $30000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.